Cargando…
Architectural Heterogeneity in Tumors Caused by Differentiation Alters Intratumoral Drug Distribution and Affects Therapeutic Synergy of Antiangiogenic Organoselenium Compound
Tumor differentiation enhances morphologic and microvascular heterogeneity fostering hypoxia that retards intratumoral drug delivery, distribution, and compromise therapeutic efficacy. In this study, the influence of tumor biologic heterogeneity on the interaction between cytotoxic chemotherapy and...
Autores principales: | Rustum, Youcef M., Tóth, Károly, Seshadri, Mukund, Sen, Arindam, Durrani, Farukh A., Stott, Emily, Morrison, Carl D., Cao, Shousong, Bhattacharya, Arup |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860580/ https://www.ncbi.nlm.nih.gov/pubmed/20445750 http://dx.doi.org/10.1155/2010/396286 |
Ejemplares similares
-
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition
por: Chintala, Sreenivasulu, et al.
Publicado: (2012) -
Non-Coding Micro RNAs and Hypoxia-Inducible Factors Are Selenium Targets for Development of a Mechanism-Based Combination Strategy in Clear-Cell Renal Cell Carcinoma—Bench-to-Bedside Therapy
por: Rustum, Youcef M., et al.
Publicado: (2018) -
Organoselenium in Nature
por: Lenardão, Eder João, et al.
Publicado: (2018) -
Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development
por: Zakharia, Yousef, et al.
Publicado: (2018) -
Design and synthesis of coumarin-based organoselenium as a new hit for myeloprotection and synergistic therapeutic efficacy in adjuvant therapy
por: Patra, Arup Ranjan, et al.
Publicado: (2018)